⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Organon sluit een akkoord voor de commercialisering van Daiichi Sankyo’s Nilemdo ® in Frankrijk, Denemarken, IJsland, Zweden, Finland en Noorwegen
businesswire.com
OGN
Organon sottoscrive un accordo di commercializzazione relativo a Nilemdo ® di Daiichi Sankyo in Francia, Danimarca, Islanda, Svezia, Finlandia e Norvegia
businesswire.com
OGN
Organon firma un acuerdo de comercialización para Nilemdo ® de Daiichi Sankyo en Francia, Dinamarca, Islandia, Suecia, Finlandia y Noruega
businesswire.com
OGN
Organon schließt Vermarktungsvereinbarung für Nilemdo ® von Daiichi Sankyo in Frankreich, Dänemark, Island, Schweden, Finnland und Norwegen
businesswire.com
OGN
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo ® in France, Denmark, Iceland, Sweden, Finland and Norway
businesswire.com
OGN
Orogen Royalties Notes Initial Resource Estimate on Kodiak Copper's MPD Copper-Gold Project
accessnewswire.com
KDK
OGN
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
businesswire.com
OGN
Henlius and Organon Announce US FDA Approval of POHERDY ® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
businesswire.com
OGN
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
businesswire.com
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2025
businesswire.com
OGN